Evidence map›Paper›PMID 30973942›Full record

ArticlePLoS pathogens2019

Increased mucosal neutrophil survival is associated with altered microbiota in HIV infection.

Tiffany Hensley-McBain, Michael C Wu, Jennifer A Manuzak, Ryan K Cheu, Andrew Gustin, Connor B Driscoll, Alexander S Zevin, Charlene J Miller, Ernesto Coronado, Elise Smith and 8 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Gut Microbiome Changes Associated With HIV Infection and Sexual Orientation.Frontiers in cellular and infection microbiology · 2020
    Pooled it
  2. Journal of bacteriology · 2026
    Review
  3. Article
  4. Maintenance of intestinal CX3CR1Nature communications · 2026
    Article
  5. Review
  6. Evaluating theFrontiers in immunology · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2023
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 3 countries.

Tiffany Hensley-McBainDepartment of Pharmaceutics, University of Washington, Seattle, WA, United States of America.
Michael C WuBiostatistics and Biomathematics Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.ORCID 0000-0002-3357-6570
Jennifer A ManuzakDepartment of Pharmaceutics, University of Washington, Seattle, WA, United States of America.ORCID 0000-0002-0079-2306
Ryan K CheuDepartment of Pharmaceutics, University of Washington, Seattle, WA, United States of America.ORCID 0000-0003-4445-3207
Andrew GustinDepartment of Pharmaceutics, University of Washington, Seattle, WA, United States of America.
Connor B DriscollDepartment of Pharmaceutics, University of Washington, Seattle, WA, United States of America.
Alexander S ZevinDepartment of Pharmaceutics, University of Washington, Seattle, WA, United States of America.
Charlene J MillerDepartment of Pharmaceutics, University of Washington, Seattle, WA, United States of America.ORCID 0000-0002-0090-6465
Ernesto CoronadoDepartment of Pharmaceutics, University of Washington, Seattle, WA, United States of America.ORCID 0000-0001-6869-8597
Elise SmithCenter for Innate Immunity and Immune Disease, Department of Immunology, University of Washington School of Medicine, Seattle, WA, United States of America.
Jean ChangCenter for Innate Immunity and Immune Disease, Department of Immunology, University of Washington School of Medicine, Seattle, WA, United States of America.
Michael GaleWashington National Primate Research Center, Seattle, WA, United States of America.ORCID 0000-0002-6332-7436
Ma SomsoukDivision of Gastroenterology, University of California, San Francisco, San Francisco, CA, United States of America.
Adam D BurgenerNational HIV and Retrovirology Labs, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Peter W HuntDivision of Experimental Medicine, University of California, San Francisco, San Francisco, CA, United States of America.
Thomas J HopeDepartment of Cellular and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States of America.
Ann C CollierDepartment of Medicine, University of Washington, Seattle, WA, United States of America.
Nichole R KlattDepartment of Pharmaceutics, University of Washington, Seattle, WA, United States of America.
Oregon National Primate Research Center · USUniversity of Washington · USUniversity of California, San Francisco · USFred Hutch Cancer Center · USNorthwestern University · USPublic Health Agency of Canada · CAUniversity of Miami · US

Funding

Washington National Primate Research CenterP51OD010425 · OD · UNIVERSITY OF WASHINGTON · PI Mari Ostendorf · 2012 to 2026
$201.8M
University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Judith Tsui · 1988 to 2026
$104.9M
Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
West Nile Virus and host control of innate defensesU19AI083019 · NIAID · UNIVERSITY OF WASHINGTON · PI CLARK, EDWARD A · 2009 to 2018
$22.5M
Innate Immune Antivirals for BiodefenseR01AI098943 · NIAID · UNIVERSITY OF WASHINGTON · PI GALE, MICHAEL · 2012 to 2016
$8.0M
Diseases of Public Health Importance Training GrantT32AI007509 · NIAID · UNIVERSITY OF WASHINGTON · PI LUND, JENNIFER M · 1997 to 2024
$6.3M
Targeting novel pathways to enhance gastrointestinal integrity during HIV infectionR01DK112254 · NIDDK · UNIVERSITY OF WASHINGTON · PI BURGENER, ADAM, KLATT, NICHOLE ROSE · 2017 to 2021
$1.8M
Joint Analysis of Microbiome and Other Genomic Data TypesR01GM129512 · NIGMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI WU, MICHAEL CHIAO-AN · 2018 to 2021
$1.6M
Impact of Malaria Co-Infection on HIV VaccinationK01OD024876 · OD · UNIVERSITY OF WASHINGTON · PI MANUZAK, JENNIFER · 2017 to 2019
$1.0M
FHCRC High-Performance Computing ClusterS10OD020069 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KOOPERBERG, CHARLES L · 2015 to 2015
$600k
NIAID NIH HHS P30 AI027757NIAID NIH HHS P30 AI027763NIAID NIH HHS R01 AI098943NIAID NIH HHS T32 AI007509NIAID NIH HHS U19 AI083019NIDDK NIH HHS R01 DK112254NIGMS NIH HHS R01 GM129512NIH HHS K01 OD024876NIH HHS P51 OD010425NIH HHS S10 OD020069
6 · The paper itself

Abstract

Gastrointestinal (GI) mucosal dysfunction predicts and likely contributes to non-infectious comorbidities and mortality in HIV infection and persists despite antiretroviral therapy. However, the mechanisms underlying this dysfunction remain incompletely understood. Neutrophils are important for containment of pathogens but can also contribute to tissue damage due to their release of reactive oxygen species and other potentially harmful effector molecules. Here we used a flow cytometry approach to investigate increased neutrophil lifespan as a mechanism for GI neutrophil accumulation in chronic, treated HIV infection and a potential role for gastrointestinal dysbiosis. We report that increased neutrophil survival contributes to neutrophil accumulation in colorectal biopsy tissue, thus implicating neutrophil lifespan as a new therapeutic target for mucosal inflammation in HIV infection. Additionally, we characterized the intestinal microbiome of colorectal biopsies using 16S rRNA sequencing. We found that a reduced Lactobacillus: Prevotella ratio associated with neutrophil survival, suggesting that intestinal bacteria may contribute to GI neutrophil accumulation in treated HIV infection. Finally, we provide evidence that Lactobacillus species uniquely decrease neutrophil survival and neutrophil frequency in vitro, which could have important therapeutic implications for reducing neutrophil-driven inflammation in HIV and other chronic inflammatory conditions.

Indexed as

ColonFemaleGastrointestinal MicrobiomeHIV-1HIV InfectionsHumansInflammationMaleMiddle AgedNeutrophilsRectum

Identifiers

PMID30973942
PMCPMC6459500
OpenAlexW2938785635

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.